Home / News / Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

26 March 2015

Posted in — Media Release

Share

Learn More

Share

You may also like

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

Media Release

02 August 2020

Hatchtech gets lice treatment nod from FDA

News, The Australian Financial Review

01 February 2018

No nit picking: Head lice group Hatchtech gets green light to trials

News, The Australian Financial Review

14 September 2015

Hatchtech inks $279m head lice deal as VC market comes to life

Sydney Morning Herald

View All

Ventured. Gained.
decor